Detalhe da pesquisa
1.
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis.
Eur J Cancer Care (Engl)
; 31(6): e13753, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273820
2.
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
Blood
; 139(6): 942-946, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34905598
3.
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective study.
Haematologica
; 108(10): 2850-2854, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994502
4.
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Haematologica
; 107(7): 1681-1686, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965701
5.
Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly.
Br J Haematol
; 170(2): 179-84, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25891777
6.
T-cell large granular lymphocyte leukemia transfomation into aggressive T-cell lymphoma: a report of two cases with molecular characterization.
Haematologica
; 104(3): e117-e120, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573508
7.
Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.
Haematologica
; 103(7): e296-e299, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29472354
8.
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era.
Viruses
; 14(11)2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366475
9.
Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.
Br J Haematol
; 153(2): 191-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21385169
10.
Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy.
Cancers (Basel)
; 13(17)2021 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503133
11.
PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.
Br J Haematol
; 170(2): 278-81, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25580881
12.
Brentuximab vedotin in heavily treated Hodgkin and anaplastic large-cell lymphoma, a single centre study on 45 patients.
Br J Haematol
; 166(2): 306-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24673542
13.
Evolution of radiotherapy techniques for mediastinal Hodgkin lymphoma: a single-center experience.
Mediastinum
; 8: 10, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38322184
14.
Pegylated liposomal doxorubicin: an efficient treatment in patients with Hodgkin lymphoma relapsing after high dose therapy and stem cell transplation.
Br J Haematol
; 162(6): 846-8, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23789905
15.
Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients.
Oncotarget
; 9(24): 16822-16831, 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682187
16.
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis.
Blood Cancer J
; 11(3): 62, 2021 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741892
17.
Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies.
Leuk Lymphoma
; 57(12): 2820-2826, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118302
18.
High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors.
Leuk Lymphoma
; 60(9): 2324-2327, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30773115
19.
Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma.
Clin Lymphoma Myeloma Leuk
; 10(4): 262-9, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20709662
20.
Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial.
Cancer Chemother Pharmacol
; 65(4): 781-90, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19960345